Description
Endurance Formula | MRM Cordyceps CS-4
If you're looking for an all natural way to boost your endurance, look no further. MRM Cordyceps CS-4 is 100% all natural and Gluten-free friendly, and is made with only the highest quality ingredients on the market. MRM Cordyceps CS-4 will help to boost the Immune System and your overall Respiratory health, and is Vegan/Vegetarian friendly. MRM Cordyceps CS-4 will help to support strength and endurance over time, and is fully transparent and generously dosed. On top of all of that, MRM's Cordyceps CS-4 is easy and convenient to take on-the-go. Step up your endurance game today with MRM. Pick up a Bottle!! Introducing MRM Cordyceps CS-4!!
MRM Cordyceps CS-4 Benefits
- 100% All Natural & Gluten-Free Friendly
- Made With All Of The Highest Quality Ingredients
- Fully Transparent & Generously Dosed
- May Help Support Immune & Respiratory Health
- Supports Strength & Endurance Over Time
- Easy & Convenient To Take On-The-Go
- Formulated With Researched CS-4 Strain
- Vegan/Vegetarian Friendly Supplement Option
How Do I Take MRM Cordyceps CS-4?
MRM recommends taking one to two (1-2) Capsules up to three (3) time daily with a Meal or as directed by your Healthcare Provider.
MRM Cordyceps CS-4 Ingredients
MRM Cordyceps CS-4 Side Effects & Warnings
Keep out of reach of children. As with all dietary Supplements, consult your Healthcare Professional before use. See product label for more information. Store in a cool, dry place. Do not exceed recommended dose.
References
Chan RCH, Lam SSW, Fong FLY, Chan DTW, Lee FWF, Sze ETP. Optimization of protein extraction and two-dimensional gel electrophoresis profiles for the identification of Cordyceps sinensis and other similar species. PLoS One. 2018;13(8):e0202779. Published 2018 Aug 22. doi:10.1371/journal.pone.0202779
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105017/
Shrestha B, Sung GH, Sung JM. Current nomenclatural changes in Cordyceps sensu lato and its multidisciplinary impacts. Mycology. 2017;8(4):293-302. Published 2017 Oct 5. doi:10.1080/21501203.2017.1386242
